A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab-Reference-Cited by-同舟云学术

A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab

Published:2018-12-20 Issue:7 Volume:25 Page:2096-2108
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Nowicki Theodore S.,Berent-Maoz Beata,Cheung-Lau Gardenia,Huang Rong Rong,Wang Xiaoyan,Tsoi Jennifer,Kaplan-Lefko Paula,Cabrera Paula,Tran Justin,Pang Jia,Macabali Mignonette,Garcilazo Ivan Perez,Carretero Ignacio Baselga,Kalbasi Anusha,Cochran Alistair J.,Grasso Catherine S.,Hu-Lieskovan Siwen,Chmielowski Bartosz,Comin-Anduix Begoña,Singh Arun,Ribas Antoni

Funder

NIH

NIHNICHDNICHD

UCLA

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors;Seminars in Immunopathology;2024-07-25

2. Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer;Journal for ImmunoTherapy of Cancer;2024-06

3. Immunotherapy in Sarcoma: Current Data and Promising Strategies;American Society of Clinical Oncology Educational Book;2024-06

4. Immune checkpoint inhibitors: breakthroughs in cancer treatment;Cancer Biology & Medicine;2024-05-24

5. Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy;Experimental Hematology & Oncology;2024-04-03